Physician profile
Friedrich Boettner
NPI 1205945409
$2,870,963.88
in general payments reported to CMS, 2019-2025
13 companies · $490K in 2025
The $490K reported for 2025 was more than what 97% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347K · 2020: $359K · 2021: $377K · 2022: $391K · 2023: $459K · 2024: $448K · 2025: $490K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Travel and Lodging: $26K · Consulting Fee: $6,075 · Debt Forgiveness: $3,280 · Food and Beverage: $2,354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,359,411.63 |
| Travel and Lodging | $25,856.42 |
| Consulting Fee | $6,075.00 |
| Debt Forgiveness | $3,279.69 |
| Food and Beverage | $2,354.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $2,433,938.45 | 2019-2025 | |
| Smith+Nephew, INC. | $388,779.04 | 2019-2024 | Legion, Legion Revision |
| Medacta USA, INC. | $25,918.20 | 2024-2025 | Amistem, Nextar Hip, Gmk Sphere |
| Medical Device Business Services, INC. | $13,294.26 | 2019-2025 | Velys |
| Johnson & Johnson Health Care Systems INC. | $3,279.69 | 2024-2025 | |
| Medtronic USA, INC. | $3,018.53 | 2019-2020 | |
| Globus Medical, INC. | $1,334.62 | 2024 | Proven Gen-Flex Ps Knee System |
| Depuy Synthes Sales INC. | $831.02 | 2022-2025 | Attune, Velys, Kincise |
| Linkbio Corp | $192.35 | 2023 | |
| Zimmer Biomet Holdings, INC. | $136.50 | 2021-2022 | |
| Engage Uni, LLC | $114.00 | 2020 | |
| Aesculap Implant Systems, LLC | $113.49 | 2020 | |
| Stryker Corporation | $13.73 | 2024 | Mako |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Friedrich Boettner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.